CAV1 and osteosarcoma: Consistent with these findings, our study found that miR-629-5p facilitated the pathological process of osteosarcoma by directly inhibiting the expression of the target gene, CAV1. Collectively, these data suggest that miR-629-5p may participate in tumorigenesis by downregulating the expression of certain molecules.